Jonathan Halford to Adult
This is a "connection" page, showing publications Jonathan Halford has written about Adult.
Connection Strength
0.346
-
A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies. Epilepsy Res. 2021 08; 174:106646.
Score: 0.052
-
Detection of generalized tonic-clonic seizures using surface electromyographic monitoring. Epilepsia. 2017 11; 58(11):1861-1869.
Score: 0.041
-
Correlation of seizure frequency and medication down-titration rate during video-EEG monitoring. Epilepsy Behav. 2016 11; 64(Pt A):51-56.
Score: 0.038
-
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures. Epilepsia. 2011 Apr; 52(4):816-25.
Score: 0.026
-
Extrahippocampal gray matter loss and hippocampal deafferentation in patients with temporal lobe epilepsy. Epilepsia. 2010 Apr; 51(4):519-28.
Score: 0.024
-
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity. Neurology. 2023 Mar 14; 100(11):e1123-e1134.
Score: 0.015
-
Dementia presenting as postpartum depression. Obstet Gynecol. 2002 May; 99(5 Pt 2):925-8.
Score: 0.014
-
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. Epilepsia. 2022 01; 63(1):139-149.
Score: 0.014
-
Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. Neurology. 2021 11 02; 97(18):e1757-e1767.
Score: 0.013
-
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020 09 01; 95(9):e1244-e1256.
Score: 0.012
-
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study. Epilepsia. 2020 06; 61(6):1099-1108.
Score: 0.012
-
Automated Processing of Single-Channel Surface Electromyography From Generalized Tonic-Clonic Seizures to Inform Semiology. J Clin Neurophysiol. 2020 Jan; 37(1):56-61.
Score: 0.012
-
Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia. 2019 03; 60(3):419-428.
Score: 0.011
-
Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures. Ann Neurol. 2018 06; 83(6):1174-1185.
Score: 0.011
-
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials. Epilepsia. 2015 Jun; 56(6):906-14.
Score: 0.009
-
Oscillating Square Wave Transcranial Direct Current Stimulation (tDCS) Delivered During Slow Wave Sleep Does Not Improve Declarative Memory More Than Sham: A Randomized Sham Controlled Crossover Study. Brain Stimul. 2015 May-Jun; 8(3):528-34.
Score: 0.009
-
Hippocampal atrophy in temporal lobe epilepsy: the 'generator' and 'receiver'. Acta Neurol Scand. 2012 Feb; 125(2):105-10.
Score: 0.007
-
Assessment of a scalp EEG-based automated seizure detection system. Clin Neurophysiol. 2010 Nov; 121(11):1832-43.
Score: 0.006
-
Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials. Epilepsia. 2010 Mar; 51(3):333-43.
Score: 0.006
-
Automated MRI analysis for identification of hippocampal atrophy in temporal lobe epilepsy. Epilepsia. 2009 Feb; 50(2):228-33.
Score: 0.005
-
Microstructural white matter abnormalities in nodular heterotopia with overlying polymicrogyria. Seizure. 2007 Jan; 16(1):74-80.
Score: 0.005
-
Asymmetrical extra-hippocampal grey matter loss related to hippocampal atrophy in patients with medial temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 2007 Mar; 78(3):286-94.
Score: 0.005